188 related articles for article (PubMed ID: 35449173)
1. Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles.
Tucker Edmister S; Del Rosario Hernández T; Ibrahim R; Brown CA; Gore SV; Kakodkar R; Kreiling JA; Creton R
Sci Rep; 2022 Apr; 12(1):6120. PubMed ID: 35449173
[TBL] [Abstract][Full Text] [Related]
2. Drug repurposing for neurodegenerative diseases using Zebrafish behavioral profiles.
Del Rosario Hernández T; Gore SV; Kreiling JA; Creton R
Biomed Pharmacother; 2024 Feb; 171():116096. PubMed ID: 38185043
[TBL] [Abstract][Full Text] [Related]
3. A zebrafish model for calcineurin-dependent brain function.
Tucker Edmister S; Ibrahim R; Kakodkar R; Kreiling JA; Creton R
Behav Brain Res; 2022 Jan; 416():113544. PubMed ID: 34425181
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcineurin inhibitors, cyclosporine A and tacrolimus (FK506), on the activity of antifungal drugs against
Şen Kaya S; Kiraz N; Bariş A; Turan D; Öz Y; Dağ İ; Aygün G
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33915075
[No Abstract] [Full Text] [Related]
5. Finding Drug Repurposing Candidates for Neurodegenerative Diseases using Zebrafish Behavioral Profiles.
Hernández TDR; Gore SV; Kreiling JA; Creton R
bioRxiv; 2023 Sep; ():. PubMed ID: 37745452
[TBL] [Abstract][Full Text] [Related]
6. Effects of embryonic cyclosporine exposures on brain development and behavior.
Clift DE; Thorn RJ; Passarelli EA; Kapoor M; LoPiccolo MK; Richendrfer HA; Colwill RM; Creton R
Behav Brain Res; 2015 Apr; 282():117-24. PubMed ID: 25591474
[TBL] [Abstract][Full Text] [Related]
7. Modulation of calcineurin signaling during development.
Tucker Edmister S; Creton R
Dev Neurobiol; 2022 Sep; 82(6):505-516. PubMed ID: 35785416
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage.
Uchino H; Ishii N; Shibasaki F
Acta Neurochir Suppl; 2003; 86():105-11. PubMed ID: 14753416
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens.
Blankenship JR; Singh N; Alexander BD; Heitman J
J Clin Microbiol; 2005 Jan; 43(1):464-7. PubMed ID: 15635017
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway.
Yu JJ; Zhang Y; Wang Y; Wen ZY; Liu XH; Qin J; Yang JL
Psychopharmacology (Berl); 2013 Jan; 225(2):361-72. PubMed ID: 22875481
[TBL] [Abstract][Full Text] [Related]
11. Effects of tacrolimus on c-fos in hippocampus and memory performances in streptozotocin model of Alzheimer’s disease of rats.
Köylü A; Altunkaynak BZ; Delibaş B
Turk J Med Sci; 2021 Aug; 51(4):2159-2166. PubMed ID: 33754647
[TBL] [Abstract][Full Text] [Related]
12. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.
Brewin J; Mancao C; Straathof K; Karlsson H; Samarasinghe S; Amrolia PJ; Pule M
Blood; 2009 Nov; 114(23):4792-803. PubMed ID: 19770360
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish Larvae Position Tracker (Z-LaP Tracker): a high-throughput deep-learning behavioral approach for the identification of calcineurin pathway-modulating drugs using zebrafish larvae.
Gore SV; Kakodkar R; Del Rosario Hernández T; Edmister ST; Creton R
Sci Rep; 2023 Feb; 13(1):3174. PubMed ID: 36823315
[TBL] [Abstract][Full Text] [Related]
14. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
Ianiri G; Applen Clancey S; Lee SC; Heitman J
mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
White M; Montezano AC; Touyz RM
Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):5-14. PubMed ID: 22184128
[TBL] [Abstract][Full Text] [Related]
16. Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats.
Brosda J; Becker T; Richter M; Jakobs M; Hörbelt T; Bendix I; Lückemann L; Schedlowski M; Hadamitzky M
Psychopharmacology (Berl); 2021 Apr; 238(4):1047-1057. PubMed ID: 33349900
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication.
Dang W; Yin Y; Wang Y; Wang W; Su J; Sprengers D; van der Laan LJW; Felczak K; Pankiewicz KW; Chang KO; Koopmans MPG; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807916
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive calcineurin inhibitor cyclosporine A induces proapoptotic endoplasmic reticulum stress in renal tubular cells.
Yilmaz DE; Kirschner K; Demirci H; Himmerkus N; Bachmann S; Mutig K
J Biol Chem; 2022 Mar; 298(3):101589. PubMed ID: 35033536
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the calcineurin/NFAT pathway.
Martínez-Martínez S; Redondo JM
Curr Med Chem; 2004 Apr; 11(8):997-1007. PubMed ID: 15078162
[TBL] [Abstract][Full Text] [Related]
20.
Lee Y; Lee KT; Lee SJ; Beom JY; Hwangbo A; Jung JA; Song MC; Yoo YJ; Kang SH; Averette AF; Heitman J; Yoon YJ; Cheong E; Bahn YS
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
